The Science of Success

1
The Science of Success
Confidential Investor Presentation Created by
Ardent Advisors
2
Safe Harbor

• Statements in this presentation that are not
  descriptions of historical facts are
  forward-looking statements relating to future
  events, and as such all forward-looking
  statements are made pursuant to the Securities
  Litigation Reform Act of 1995. Statements may
  contain certain forward-looking statements
  pertaining to future anticipated or projected
  plans, performance and developments, as well as
  other statements relating to future operations
  and results. Any statements in this presentation
  that are not statements of historical fact may be
  considered to be forward-looking statements.
  Words such as "may," "will," "expect," "believe,"
  "anticipate," "estimate," "intends," "goal,"
  "objective," "seek," "attempt," or variations of
  these or similar words, identify forward-looking
  statements. These forward-looking statements by
  their nature are estimates of future results only
  and involve substantial risks and uncertainties,
  including but not limited to risks associated
  with the uncertainty of future financial results,
  additional financing requirements, development of
  new products, successful completion of the
  Companys proposed restructuring, the impact of
  competitive products or pricing, technological
  changes, the effect of economic conditions and
  other uncertainties detailed from time to time in
  our reports filed with the Securities and
  Exchange Commission. There can be no assurance
  that our actual results will not differ
  materially from expectations and other factors
  more fully described in our public filings with
  the U.S. Securities and Exchange Commission,
  which can be reviewed at www.sec.gov.

3
Corporate Profile

• Inergetics, Inc. (NRTI) is a leading developer
  of patented nutritional products comprised of
  high-quality ingredients and proprietary
  formulations. The Company is leading the way in
  nutritional excellence with targeted brands that
  independently serve the Clinical Oncology, Long
  Term Care (Senior Care), and Sports Nutrition
  Markets.
• Financial Guidance (millions)
• Next 12 Months (Assumes calendar year end changed
  to FYE June 30th)
• Stock Symbol OTC NRTI
• Shares Outstanding 31,092,796
• Closing Stock Price as of 4/27/10 1.20
• Average Volume (3 months) 19,086
• Additional Paid in Capital 55,188,466
• Net Operating Loss (carry forward)
  68,388,118

Assumes 60 to 1 reverse split ( Date TBD)
4
Recapitalization Corporate Changes

• Initial recapitalization in November 2009
• Eliminated 13,500,000 of current liabilities
• Converted 7,700,000 of unsecured debt into
  equity at 2.10 a share
• Wrote off 3,000,000 of secured debt
• Raised 1,382,050 of new capital in
  senior secured debenture
• Secondary recapitalization in May 2010
• Raised an additional 1,187,500 in extended
  offering
• Changed name from Millennium Biotechnologies
  Group, Inc. to Inergetics, Inc.
• Changed ticker from MBTG to NRTI
• Announced 60 to 1 stock reverse (Date TBD)
• Changing calendar year end to FYE June 30th
• Converting newly issued senior secured debt to
  equity at 1.20 per share
• Senior secured debt outstanding 3,134,510 as of
  6/8/10
• Converted 2,664,838 as of 6/8/10
• Balance Sheet Comparative Analysis

5
NRTI Product Portfolio
Clinical Nutrition
Performance Nutrition

• SURGEX
• Sports Government
• Powder and RTD (in dev)

• RESURGEX Select
• Oncology HIV
• Easy to use powder

• RESURGEX Essential
• Long Term Care Home Care
• Ready to Drink

6
Resurgex Oncology
Product

• Comprehensive nutritional support for actively
  treated cancer patients as well as those in
  post-treatment care
• National Federal Medicare HCPCS Coding Medicaid
  Approval in various States
• Over 4 million servings consumed over past decade
• Powder formulations
• Unique whole foods based quality ingredient
  formula to assist in weight maintenance, reduce
  fatigue and support immunity
• Prescribed by leading Oncology Institutions such
  as Dana Farber MD Anderson
• Clinical Trials
• Center for Family Of Health , UMDNJ/ St Mary's
  Hospital
• Columbia University Pediatric Oncology Clinical
  Trial
• Over 1.5mm new cancer cases annually and 13
  million survivors
• Only options are unhealthy alternatives such as
  Ensure and Boost
• 90 of cancer patients face fatigue
• Over 60 cancer patients look to Complementary
  and Alternative Medicine (CAM) to complement
  their treatment

Point of Difference
Market Opportunity
U.S. Complete Prevalence Counts, Invasive
Cancers Only, 1/1/2006 - U.S. 2006 cancer
prevalence counts are based on 2006 cancer
prevalence proportions from the SEER 9 registries
(San Francisco, Connecticut, Detroit, Hawaii,
Iowa, New Mexico, Seattle, Utah, and Atlanta) and
1/1/2006 U.S. population estimates based on the
average of 2005 and 2006 population estimates
from the U.S. Bureau of the Census. Estimated
new Cancer Cases and Deaths for 2009 Cancer
Facts Figures 2009, American Cancer Society
(ACS), Atlanta, Georgia, 2009.
7
Resurgex Essential LTC

• Comprehensive, caloric dense formulations that
  exceed the nutritional requirements of the Long
  Term Care community
• Natural extension of heritage in addressing the
  needs of the elderly
• Ready-to-Drink (RTD) formulations in easy to
  administer Tetra Paks
• Great tasting premium nutritional drink,
  fortified with high-quality ingredients
• High Biological Whey Protein
• No high fructose corn syrup, high MCTs, low
  Omega 6
• Contains fruit vegetable powders, less sugar
• Excellent for weight maintenance and wound
  healing
• Helps maintain body weight, support a healthy
  G.I. tract and keeps bodies strong
• According to the American Healthcare Association,
  as of December 2008
• 1,410,900 residents lived in Skilled Nursing
  Facilities
• 1,100,000 residents lived in Assisted Living
  Facilities
• 7,600,000 individuals were receiving Home Care
  from gt 17,000 providers
• Alternatives are unhealthy alternatives such as
  Ensure and Boost

Product
Point of Difference
Market Opportunity
7
8
Resurgex Essential Comparative Composition
9
Surgex Sports

• Comprehensive, caloric dense formulations that
  exceed the nutritional requirements of the
  athletic community
• Natural extension of heritage in addressing the
  needs of the athletically inclined
• Bulk and individual servings in powder format and
  TetraPak RTD format
• Unique high performing formula with the only form
  of water soluble Superoxide Dismutase (SOD) which
  is clinically proven to help cells adapt to
  stress
• Surgex is the only nutritional supplement
  clinically proven to to increase energy, build
  lean muscle mass, increase strength and power,
  increase endurance and boost recovery and
  immunity
• NCAA compliant approved by the Banned Substances
  Control Group
• According to BCC Research, Sports Nutrition and
  High Energy Supplements The Global Market
  9/17/08, the Global Sports Nutrition Market is
  estimated 27 Billion
• Industry segments
• Sports Beverages 24.9 Billion
• Sports Food 1.2 Billion
• Sports Nutrition Supplements 1.1 Billion
• Alternative products have no scientific evidence
  to support claims

Product
Point of Difference
Market Opportunity
9
10
The Science of Success- Superoxide Dismutase
(SOD)

• SOD is the bodys (cells) most important
  antioxidant and plays a major role in many
  pathological conditions  
• Cardiovascular Issues, Exercise/Stress Response,
  Inflammation
• Pulmonary edema, rheumatoid arthritis,
  Alzheimer's, cancer, asthma
• GliSODin, a patented, orally effective
  ingredient, clinically shown to
• Promote the production of the bodys own natural
  antioxidants
• Help maintain cellular health and protect against
  oxidative stress damage
• Reduce lactic acid buildup in humans under
  physical stress
• Support healthy immune function
• GliSODin) The First Orally Effective SOD
• Pharmaceutical compositions comprising a
  superoxide dismutase 
• (CEE. 96 901 386-1, USA. 6 04 5809 and Japan
  HEI.8 1996 520 6 16)
• The patent describes the first oral composition
  of SOD using vegetal prolamines (gliadin) as
  natural support for oral delivery
• New therapeutics use of heterologous SOD and
  their process of selection 
• (CEE 99 901 386-1 USA 09/600 062 and Japan HEI
  2000. 527633)
• The patent describes the mechanism of action of
  heterologous SODs and details new therapeutic
  applications

11
The Science of Success- Superior Ingredients
Whey Protein Fast acting, easy to digest protein with a superior biological value that helps preserve lean muscle mass and supports immunity
Vitamin D Twice the RDA recommended amount to support bone health, muscle strength and immunity
FOS High quality fiber that supports healthily GI tract and normalize bowel function to help with the most common conditions in elderly
Fruits Vegetables Juice powders from many healthy ingredients blended together to contribute whole food phytonutrients and antioxidants
Low Carbohydrates Resurgex products are lower in simple carbohydrates, which is important for good blood sugar control. In addition, they do not contain high fructose corn syrup which has been shown in studies to increase risk of insulin resistance.
No Trans Fats Not only are Resurgex products cholesterol free, but it also contains Monounsaturated Fatty Acids which has been proven in research studies to lower LDL (bad) cholesterol. The Monounsaturated Fat in Resurgex is in the form of high oleic Safflower oil rather than corn oil. Other brands use corn oil, which is high in Omega-6 Fatty Acids.
12
Surgex Clinical Validation

• Rutgers University conducted two single-blinded,
  controlled studies to establish the clinical
  efficacy of Surgex?
• Clinical Study I Rutgers endurance athletes
  (Mens Division 1 Soccer Team) saw a dramatic
  improvement, compared to Boost, in recovery and
  performance parameters
• Clinical Study II Rutgers strength athletes
  (Mens Division 1 Football Team) saw a dramatic
  improvements in recovery, strength and endurance
  when compared to Gatorade Sports Nutritional
  Product
• Performance Results Validation
• Improvements in Performance, Lactic Acid
  Response, Reduced Oxidative Stress
• Significant changes in performance capacity and
  endurance markers
• Less soreness and fatigue following intense
  training sessions
• Significantly lower oxidative stress markers,
  isoprostanes and LPOs
• Improvements in Power Body Composition Recovery
  Parameters
• Significant increase in peak power as measured by
  Wingate Testing
• Increased lean muscle mass and decreased in
  weight gain as body fat
• Significantly improved testosterone cortisol
  ratio
• Significantly lower ILS, Creatine Kinase,
  Isoporstanes

13
Surgex Comparative Composition
14
The Science of Success- Intellectual Property

• Patents Trademarks
• Resurgex was issued U.S. Patent 6,503,506 for
  nutrient therapy for immuno-compromised patients
  on January 7th, 2003.
• Patents pending in 57 countries worldwide
• 4 Registered trademarks filed with the U.S.
  Patent and Trademark Office (USPTO)
• Clinical Partners
• Center for Family Of Health , UMDNJ/ St Mary's
  Hospital
• Rutgers University
• Division 1 Soccer Double Blind, Placebo
  Controlled Study on Universitys Soccer Team
• Division 1 Football Double Blind, Placebo
  Controlled Study on Universitys Football Team
• Columbia University Division of Pediatric
  Oncology
• Scheduled to occur during the summer of 2010 and
  last for 12 weeks
• Multi-site study at St. Jude Children's Research
  Hospital (SJCRH), Alberta Health Services, and
  the Regional Cancer Center (RCC) at Capital
  Health.
• Industry Journals
• The Journal of Strength Conditioning Research
• Published Rutgers Soccer Study
• Comparative Exercise Physiology
• Published the Rutgers Football Study

15
Strategic Distribution Partners

• Windmill Health Products LLC, is a leading
  marketer and distributor of lifestyle nutritional
  products to all major classes of trade, including
  Food, Drug, Mass Market Retailers, Health Food
  Retailers and various distributors.
• KTK Business Development Group, LLC, is a leading
  government contracting process consultant for
  small and medium businesses. KTK provides the
  business development, contract support, a
  proprietary partner community, grant writing
  services, and certification services to become
  GSA vendor
• Ferring Inc. (Canada), a wholly owned subsidiary
  of Ferring Pharmaceuticals, Inc., is the
  Companys Canadian distributor and co-marketer of
  Resurgex products.  With corporate headquarters
  in Saint-Prex, Switzerland, operate from more
  than 45 countries and employ more than 3700
  people throughout the world, while treatments are
  available in more than 70 countries.
• New Marketlink Pharmaceutical Corp. (NMPC), a
  Filipino-owned and managed corporation, is
  engaged in importation, sales, promotion and
  distribution of a diverse specialty line of
  pharmaceutical and related products.  NMPC has
  strategic manpower of 151 sales personnel and
  managers covering more  than 15,000 physicians
  nationwide.
• Provider Services Inc. (PSI) is the second
  largest operator of LTC facilities in the state
  of Ohio. Inergetics is the exclusive provider of
  nutritional supplementation products to PSIs
  6,000 beds, per the 5 year Master Purchase
  Agreement.
• Ventiv Commercial Services, a wholly owned
  subsidiary of NASDQ-listed inVentiv Health Inc.
  (VTIV), provides two (2) full time personnel,
  with over 30 years experience, to market and sell
  Resurgex Essential and Resurgex Essential Plus
  into the Long Term Care Channel.

16
Manufacturing Partners

• Isocell SA, a French Company owns the patented
  rights to the only oral form of superoxide
  dismutase (SOD). Inergetics has an exclusive
  sublicense for use of SOD as a dietary supplement
  or functional foods worldwide.
• TetraPak USA, a leader in innovative packaging
  and state-of-the-art processing solutions, that
  provides the packaging for the Resurgex Select
  RTD product lines.
• Kerry Food Beverage, Inc., a leader in the
  global food industry, developing, producing and
  marketing lifestyle and nutritional foods,
  flavors and ingredients, meeting todays consumer
  demands for healthy, convenient, tasteful food
  and beverages.
• Garden State Nutritionals, Inc. (GSN) a division
  of Vitaquest International, Inc. the worlds
  leading manufacturer of lifestyle specific
  nutritional supplements, manufacturers the
  Inergetics Surgex product line.
• Farmland Dairies, LLC recently purchased by
  Grupo LALA and is now part of LALA-National Dairy
  Group, is the Companys outsourced manufacturer
  and co-packager for the Companys RTD Essential
  product line in its kosher designated, aseptic
  facility in Grand Rapids, MI.

17
Pro Forma Capitalization Table

• 60 to 1 Reverse Stock Split (Announcement Date
  TBD)
• Pro Forma shares issued and outstanding
• Float 20,195,339
• Shares Outstanding 30,483,532
• Fully Diluted Shares 31,078,561
• Strong Management Alignment
• Executive ownership 10.10
• Ken Sadowsky (Board Member) 6.71
• Strong Institutional Ownership
• Triage Capital 16.94
• Seahorse Enterprises, LLC 7.86
• Charlie Lanktree 6.89
• Ardent Advisors (Brian Corbman) 5.40

18
Pro Forma Guidance
19
Executive Officers

• Mark C. Mirken, CEO Chairman has been
  Inergetics President Chief Executive Officer
  since August 2008. He has transitioned the
  companys major revenue sources from a powdered
  formulation to Ready-to-Drink (RTD) formulations
  and established contractual relationships with
  major pharmaceutical and international
  distributors. Additionally, Mark has increased
  shareholder value via overseeing the
  restructuring of the Companys financial
  position. Previously, Mr. Mirken was affiliated
  with Vista Research Inc., a Standard Poors
  business unit, where he consulted The Middleby
  Corp. (NASDAQ MIDD), Pequot Capital, Fidelity
  Family of Funds, and KKR on various acquisitions
  Prior, he was President COO, of TurboChef
  Technologies, Inc. (OVEN) a world leader in
  technology, equipment services, for high-speed
  food preparation (2000-2005). Mr. Mirken was
  credited creating the strategic alliance with
  Coke and engineering the Coke, Subway agreement
  and enhanced shareholder value by over 1,000.
• Carl Germano, RD, CNS, CDN is a registered,
  certified clinical nutritionist appointed as
  Chief Science Officer/Research Product
  Development for Inergetics, Inc. and a frequent
  radio guest and lecturer. He holds a masters
  degree in clinical nutrition from New York
  University and has over 30 years experience using
  innovative, complementary nutritional therapies
  in private practice and in product development. 
  For the past 25 years, he has dedicated his
  efforts to research and product development for
  the nutritional supplement industry (medical
  foods, functional beverages and dietary
  supplements), where he has been instrumental in
  bringing cutting-edge nutritional substances and
  formulations to market.  He is the author of the
  following books
• SOD/Gliadin - The Ultimate Cellular Defense
  Against Ageing and Disease,
• Nucleotides - The Buliding Blocks To Optimal
  Health,
• Rhodiola rosea - Natures Answer To Stress,  
• The Osteoporosis Solution,  
• The Brain Wellness Plan,
• Natures Pain Killers

20
Executive Officers Board of Directors

• Frank Guarino III, CFO is the Chief Financial
  Officer and is responsible for corporate
  budgeting, SEC compliance, and corporate
  operations. He maintains institutional
  relationships with the Companys investor base
  and actively participates in all funding. Mr.
  Guarino earned a Bachelor of Science in
  Accounting from St. Peters College in 1997.
• Benjamin R Custodio, Executive Vice President and
  Board Member, As Executive Vice President of
  International Sales, Mr. Custodio is responsible
  for expanding the Companys product line
  globally. Mr. Custodio has over 30 years of
  experience in the pharmaceutical and nutritional
  supplement industries, specializing in launching
  new products into international markets.
• Ken Sadowsky, Board Member, Mr. Sadowsky was a
  principal of Atlas Distributing Inc., overseeing
  the non-alcoholic beverage division which he
  created. The division was founded in 1988 and
  sales were 50,000 that year. In 2007 sales were
  over 16,000,000 and the total company sales were
  in excess of 75 million. He was a director of
  Energy Brands, Inc. (Glaceau) makers of Glaceau
  vitaminwater, smartwater, and fruitwater from
  2000 to 2006 when the company sold a minority
  interest to The Tata Group. The company
  eventually sold to Coca Cola for over 4.1
  Billion. Ken is the Senior Beverages Advisor for
  Verlinvest, a Brussels based investment holding
  company founded by family tied to Interbrew now
  ABI (Anheuser Busch InBev). Ken is the Executive
  Director of NIDA, a group of independent beverage
  distributors in the Northeast of the USA who are
  members of a trade association. Mr. Sadowsky is
  a member of the Board of Directors for All Market
  Inc., makers of Vita Coco coconut water and Hint
  Inc., makers of Hint Water.
• Michael C. James, Board Member is the Managing
  Partner of Kuekenhof Capital Management.
  Previously he served as CEO of Nestor, Inc., and
  is a director of Guided Therapeutics, Inc. Mr.
  James has accepted the nomination to the
  Companys board of directors which is subject to
  shareholder approval

21
Investment Summary

• Superior Products
• Resurgex? is clinically validated to improve
  Quality of Life indicators for HIV/AIDS
  patients
• Surgex? is clinically validated to improve
  athletic performance through optimized recovery
• Favorable Macro Industry Trends
• Growth in aging population
• Trend toward healthy living
• Science-based products supported by healthcare
  professionals
• Management team led by CEO Mark Mirken
• Proven track record of creating shareholder value
• Public market experience
• Minimal corporate capital needs
• Additional working capital required 2.5mm
• Pro Forma Financials (Fiscal Year ends June 30th)
• FY10A revenue of 2.05M and EBITDA of (1.32M)
• FY11E revenue of 23.5M and EBITDA of 4.06M

22
Inergetics NRTI